FOR US HEALTHCARE PROFESSIONALS ONLY

The safety and tolerability of INVEGA HAFYERA^® were similar to that seen with INVEGA TRINZA^®¹

Evaluated in a noninferiority study and an open-label extension study

Glucose and lipid levels evaluated in a noninferiority study

Incidence of extrapyramidal symptoms evaluated in a noninferiority study

Change in prolactin levels evaluated in a noninferiority study

Reference: 1. INVEGA HAFYERA^® [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc.

The safety and tolerability of INVEGA HAFYERA® were similar to that seen with INVEGA TRINZA®1